<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PSA Rising Prostate Cancer Blog &#187; CB7630 (abiraterone acetate)-Cougar</title>
	<atom:link href="http://www.psa-rising.com/blog/category/pca/pca-tx/hormonal/abiraterone/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.psa-rising.com/blog</link>
	<description></description>
	<lastBuildDate>Tue, 16 Aug 2011 09:39:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Cougar&#8217;s CB7630 (abiraterone acetate) trial results</title>
		<link>http://www.psa-rising.com/blog/2007/05/cougars-cb7630-abiraterone-acetate-trial-results/</link>
		<comments>http://www.psa-rising.com/blog/2007/05/cougars-cb7630-abiraterone-acetate-trial-results/#comments</comments>
		<pubDate>Thu, 31 May 2007 14:44:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[CB7630 (abiraterone acetate)-Cougar]]></category>
		<category><![CDATA[Clinical trials]]></category>
		<category><![CDATA[Hormonal-ADT]]></category>
		<category><![CDATA[Hormone refractory]]></category>
		<category><![CDATA[Prostate Cancer]]></category>

		<guid isPermaLink="false">http://psa-rising.com/blog/index.php/2007/05/31/cougars-cb7630-abiraterone-acetate-trial-results</guid>
		<description><![CDATA[Cougar Biotechnology&#8217;s once-daily oral drug CB7630 (abiraterone acetate), based on recently announced trial results, appears o have some efficacy at two stages of the standard treatment path for androgen independent prostate cancer &#8212; either before or after chemotherapy. A UK Phase I/II trial of CB7630 reports positive signs among a small number of patients enrolled [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2007/05/cougars-cb7630-abiraterone-acetate-trial-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

